When is Abnehmspritze Test actually useful?

The question of when a 'weight loss injection test' is actually useful is valid, but current scientific evidence is weak. The provided context contains no validated genetic markers that predict response or side effects to GLP-1 agonists (e.g., semaglutide). Most commercial DNA tests claiming to analyze suitability for such injections rely on mechanistic hypotheses or association studies with small effect sizes, not on randomized controlled trials. Clinical factors such as BMI, insulin resistance, liver function, and comorbidities are far more decisive. A test might offer hints about general metabolic variants (e.g., FTO, MC4R), but effect sizes are small and ancestry-dependent. Without robust human evidence, the test is not recommended for individual treatment decisions. Safety note: weight loss injections are prescription-only and can cause nausea, pancreatitis, or gallstones. A genetic test does not replace medical consultation. Evidence grade: marketing/unclear.